Cellectar Biosciences, Inc. (CLRB) stock
CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.92−0.09 (-8.88%)
Close on Nov 17, 2026Market cap $8.70MP/E –Yield –
Cellectar Biosciences total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cellectar Biosciences's total debt was $0 at Dec 31, 2016. For fiscal 2016 it was $0, down 100.0% from the year before. The highest annual figure on record is $920.94K in fiscal 2010.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $0 | -100.0% |
| FY2015 | Dec 31, 2015 | $86.63K | -73.8% |
| FY2014 | Dec 31, 2014 | $330.08K | -26.6% |
| FY2013 | Dec 31, 2013 | $450.00K | 0.0% |
| FY2012 | Dec 31, 2012 | $450.00K | 0.0% |
| FY2011 | Dec 31, 2011 | $450.00K | -51.1% |
| FY2010 | Dec 31, 2010 | $920.94K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?